Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
Indexy online
AD Index online
select
AD Index online
 

  • 02.02.2026 12:44:46
Burcon Rg (Frankfurt)
Závěr k 13.2.2026 Změna (%) Změna (EUR) Objem obchodů (EUR)
1,15 1,77 0,02 1 367
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 14.02.2026
Popis společnosti
Obecné informace
Název společnostiBurcon NutraScience Corp
TickerBU
Kmenové akcie:Ordinary Shares
RICBU.TO
ISIN-
Poslední známé roční výsledky31.03.2025
Poslední známé čtvrtletní výsledky31.12.2025
Počet zaměstnanců k 31.03.2025 15
Akcie v oběhu k 10.12.2025 12 692 276
MěnaCAD
Kontaktní informace
Ulice490-999 West Broadway
MěstoVANCOUVER
PSČV5Z 1K5
ZeměCanada
Kontatní osoba 
Funkce kontaktní osoby 
Telefon16 047 330 896
Fax16047330896

Business Summary: Burcon NutraScience Corporation is a Canada-based global technology company focused on the development of plant-based proteins for foods and beverages. The Company has an extensive patent portfolio covering its novel plant-based proteins derived from pea, canola, soy, hemp and sunflower seeds, among other plant sources. It is engaged in the production of hemp protein isolate and the provision of contract research services. Its products include hempseed protein, canola protein, pea proteins and protein blends. Its hempseed protein isolate extraction and purification/production process can produce a high-quality protein ingredient that contains 95% pure protein. It extracts and purifies a canola protein isolate from canola meal. It has branded this protein isolate under the trade name Puratein C. It provides consulting and contract services, product and process development, and process scale-up and validation. It also operates a protein production facility located in Galesburg, Illinois.
Financial Summary: BRIEF: For the six months ended 30 September 2025, Burcon NutraScience Corp revenues increased from C$277K to C$699K. Net loss increased 67% to C$7.1M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects The development of plant-based proteins segment loss increase of 36% to C$5.4M.
Odvětvová klasifikace
TRBC2009Biotechnology / Medical Research
TRBC2012Special Foods & Wellbeing Products
RBSS2004Biotechnology
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSResearch and Development in Biotechnology (except Nanobiotechnology)
NAICSResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
NAICSMedicinal and Botanical Manufacturing
NAICSSoybean and Other Oilseed Processing
NAICSSoybean Processing
NAICSAll Other Miscellaneous Food Manufacturing
NAICSResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
NAICS2007Soybean Processing
NAICS2007Other Oilseed Processing
NAICS1997Soybean Processing
NAICS1997Other Oilseed Processing
SICCommercial Physical Research
SICEdible Fats And Oils, Nec
SICSoybean Oil Mills
SICMedicinals And Botanicals
SICFood Preparations, Nec



  • Poslední aktualizace: 14.02.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive OfficerKip Underwood-07.11.202207.11.2022
Interim Chief Financial OfficerAlex Varty-04.08.202504.08.2025
Senior Vice President - Legal, Corporate SecretaryDorothy Law-20.04.201029.12.1998
Senior Vice President - ProcessRandy Willardsen-30.11.200130.11.2001
Vice President - Technical DevelopmentMartin Schweizer-